Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REBOL Technologies is a software company founded in 1997 by Carl Sassenrath, the architect of the Amiga multitasking operating system. The company is centered around the REBOL programming language, a cross-platform data exchange and messaging language designed to minimize software complexity through domain-specific dialects. While primarily a general-purpose software firm, its technology is utilized in life sciences for chemo-bio-informatics applications, notably as the scripting engine for the VEGA ZZ molecular modeling platform. REBOL's architecture emphasizes small, efficient, and highly portable code suitable for distributed network communications and automated scientific procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REBOL Technologies.